Physician profile
Mark Kozak
NPI 1477501146
$3,525.00
in general payments reported to CMS, 2019-2025
17 companies · $2,193 in 2025
The $2,193 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $203 · 2021: $11.69 · 2023: $399 · 2024: $402 · 2025: $2,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,727 · Travel and Lodging: $1,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.69 |
| Travel and Lodging | $1,267.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,583.84 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $137.06 | 2019-2024 | Mitraclip |
| Boston Scientific Corporation | $117.94 | 2019-2025 | General - Structural Heart, Jetstream Sc |
| Ancora Heart, INC. | $117.72 | 2025 | Accucinch |
| Asahi Intecc USA, INC. | $115.90 | 2024 | Peripheral Vascular |
| Shockwave Medical, INC | $93.67 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $85.15 | 2023 | Guideliner |
| Stryker Corporation | $49.21 | 2025 | Flowtriever |
| Medtronic, INC. | $46.20 | 2021-2025 | Symplicity G3 |
| Atricure, INC. | $44.81 | 2025 | Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $43.36 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Getinge USA Sales, LLC | $31.57 | 2020 | |
| Philips North America LLC | $24.95 | 2025 | Coronary Other |
| Medtronic Vascular, INC. | $23.28 | 2020 | |
| Cvrx, INC. | $10.34 | 2024 | Barostim Neo System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kozak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.